Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude

World Journal of Gastroenterology

Volumn 18, Issue 29, 2012, Pages 3889-3895

  Kuroda, Hidekatsu ^a   Kakisaka, Keisuke ^a   Kamiyama, Naohisa ^b   Oikawa, Takayoshi ^a   Onodera, Mio ^a   Sawara, Kei ^a   Oikawa, Kanta ^a   Endo, Ryujin ^a   Takikawa, Yasuhiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

Acoustic structure quantification; Animal model; Focal disturbance ratio; Non alcoholic fatty liver disease; Quantitation of hepatic steatosis; Ultrasonography

Indexed keywords

FAT DROPLET; LEPTIN;

ACOUSTIC ANALYSIS; ACOUSTICAL STRUCTURE QUANTIFICATION; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE SEVERITY; FATTY LIVER; FOCAL DISTURBANCE RATIO; GROUPS BY AGE; MALE; MOUSE; NONHUMAN; RADIOLOGICAL PROCEDURES; ULTRASOUND;

EID: 84864835957     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i29.3889     Document Type: Article

References (24)

1. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321
2. Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8: 861-79, ix.
3. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32: 381-387
4. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584
5. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861-867
6. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438
7. Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F. Nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg 2005; 15: 442-446
8. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112
9. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140
10. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238
11. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500
12. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906
13. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750
14. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468
15. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12: 487-495
16. Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the "bright liver"). Br J Radiol 1979; 52: 184-188
17. Yamaguchi T, Hachiya H, Kamiyama N, Moriyasu F. Examination of the spatial correlation of statistics information in the ultrasonic echo from diseased liver. Jpn J Appl Phys 2002; 41: 3585-3589
18. Yamaguchi T, Hachiya H, Kamiyama N, Ikeda K, Moriyasu F. Estimation of characteristic of echo envelope using RF echo signal from the liver. Jpn J Appl Phys 2001; 40: 3900-3904
19. Kamiyama N, Yamaguchi T, Hachiya H. Tissue characterization using statistical information from ultrasound echo signals. Med Imag Tech 2003; 21: 112-116
20. Toyoda H, Kumada T, Kamiyama N, Shiraki K, Takase K, Yamaguchi T, Hachiya H. B-mode ultrasound with algorithm based on statistical analysis of signals: evaluation of liver fibrosis in patients with chronic hepatitis C. AJR Am J Roentgenol 2009; 193: 1037-1043
21. Burckhardt CB. Speckle in ultrasound B-mode scans. IEEE Transactions on Sonics and Ultrasonics 1978; 25: 1-6
22. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25-29
23. Lupsor M, Badea R. Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Rom J Gastroenterol 2005; 14: 419-425
24. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419